SPOP targets the immune transcription factor IRF1 for proteasomal degradation
© 2023, Schwartz, Vunjak, Budroni et al..
Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription factor in driving the expression of immune response genes during infection. The striking difference in functional output with other IRFs is that IRF1 also drives the expression of various cell cycle inhibiting factors, making it an important tumor suppressor. Thus, it is critical to regulate the abundance of IRF1 to achieve a 'Goldilocks' zone in which there is sufficient IRF1 to prevent tumorigenesis, yet not too much which could drive excessive immune activation. Using genetic screening, we identified the E3 ligase receptor speckle type BTB/POZ protein (SPOP) to mediate IRF1 proteasomal turnover in human and mouse cells. We identified S/T-rich degrons in IRF1 required for its SPOP MATH domain-dependent turnover. In the absence of SPOP, elevated IRF1 protein levels functionally increased IRF1-dependent cellular responses, underpinning the biological significance of SPOP in curtailing IRF1 protein abundance.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
eLife - 12(2023) vom: 25. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Schwartz, Irene [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 11.09.2023 Date Revised 18.09.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.7554/eLife.89951 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361212410 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361212410 | ||
003 | DE-627 | ||
005 | 20231226084643.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7554/eLife.89951 |2 doi | |
028 | 5 | 2 | |a pubmed24n1203.xml |
035 | |a (DE-627)NLM361212410 | ||
035 | |a (NLM)37622993 | ||
035 | |a (PII)e89951 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Schwartz, Irene |e verfasserin |4 aut | |
245 | 1 | 0 | |a SPOP targets the immune transcription factor IRF1 for proteasomal degradation |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.09.2023 | ||
500 | |a Date Revised 18.09.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023, Schwartz, Vunjak, Budroni et al. | ||
520 | |a Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription factor in driving the expression of immune response genes during infection. The striking difference in functional output with other IRFs is that IRF1 also drives the expression of various cell cycle inhibiting factors, making it an important tumor suppressor. Thus, it is critical to regulate the abundance of IRF1 to achieve a 'Goldilocks' zone in which there is sufficient IRF1 to prevent tumorigenesis, yet not too much which could drive excessive immune activation. Using genetic screening, we identified the E3 ligase receptor speckle type BTB/POZ protein (SPOP) to mediate IRF1 proteasomal turnover in human and mouse cells. We identified S/T-rich degrons in IRF1 required for its SPOP MATH domain-dependent turnover. In the absence of SPOP, elevated IRF1 protein levels functionally increased IRF1-dependent cellular responses, underpinning the biological significance of SPOP in curtailing IRF1 protein abundance | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a human | |
650 | 4 | |a immunology | |
650 | 4 | |a inflammation | |
650 | 4 | |a interferon regulatory factor 1 | |
650 | 4 | |a mouse | |
650 | 4 | |a proteasome | |
650 | 4 | |a protein degradation | |
650 | 4 | |a ubiquitin | |
650 | 7 | |a Interferon Regulatory Factor-1 |2 NLM | |
650 | 7 | |a SPOP protein, human |2 NLM | |
650 | 7 | |a Immunologic Factors |2 NLM | |
650 | 7 | |a IRF1 protein, human |2 NLM | |
700 | 1 | |a Vunjak, Milica |e verfasserin |4 aut | |
700 | 1 | |a Budroni, Valentina |e verfasserin |4 aut | |
700 | 1 | |a Cantoran García, Adriana |e verfasserin |4 aut | |
700 | 1 | |a Mastrovito, Marialaura |e verfasserin |4 aut | |
700 | 1 | |a Soderholm, Adrian |e verfasserin |4 aut | |
700 | 1 | |a Hinterndorfer, Matthias |e verfasserin |4 aut | |
700 | 1 | |a de Almeida, Melanie |e verfasserin |4 aut | |
700 | 1 | |a Hacker, Kathrin |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jingkui |e verfasserin |4 aut | |
700 | 1 | |a Froussios, Kimon |e verfasserin |4 aut | |
700 | 1 | |a Jude, Julian |e verfasserin |4 aut | |
700 | 1 | |a Decker, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Zuber, Johannes |e verfasserin |4 aut | |
700 | 1 | |a Versteeg, Gijs A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t eLife |d 2012 |g 12(2023) vom: 25. Aug. |w (DE-627)NLM221831460 |x 2050-084X |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2023 |g day:25 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.7554/eLife.89951 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2023 |b 25 |c 08 |